Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome

Obstetrics and Gynecology

Volumn 114, Issue 5, 2009, Pages 1076-1084

  Stekkinger, Eva ^a   Zandstra, Mirjam ^a   Peeters, Louis L H ^a   Spaanderman, Marc E A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME;

ADULT; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ECLAMPSIA; FEMALE; HELLP SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; METABOLIC SYNDROME X; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; SOLUTIO PLACENTAE; STILLBIRTH; WORLD HEALTH ORGANIZATION;

ADULT; ALBUMINURIA; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; DELIVERY, OBSTETRIC; FASTING; FEMALE; GESTATIONAL AGE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; METABOLIC SYNDROME X; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PUERPERAL DISORDERS; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 73549120198     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181b7b242     Document Type: Article

References (32)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-22.
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553
4. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-1778
5. 5. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072 (Pubitemid 43113437)
6. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007;50:938-948
7. 7. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 1999;48:892-896 (Pubitemid 29310046)
8. Lorentzen B, Birkeland KI, Endresen MJ, Henriksen T. Glucose intolerance in women with pre-eclampsia. Acta Obstet Gynecol Scand 1998;77:22-27
9. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85:353-356
10. 10. Crispi F, Domínguez C, Llurba E, Martín-Gallán Cabero L, Gratacós E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006;195:201-207 (Pubitemid 43927524)
11. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG 2004;111:298-302.
12. 12. Hall DR, Odendaal HJ, Kirsten GF, Smith J, Grové D. Expectant management of early onset, severe pre-eclampsia: perinatal outcome. BJOG 2000;107:1258-1264 (Pubitemid 30736195)
13. 13. Hall DR, Odendaal HJ, Steyn DW, Grove D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000;107:1252-1257 (Pubitemid 30736194)
14. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001;323:1213-1217
15. 15. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63. (Pubitemid 30022895)
16. 16. Aardenburg R, Spaanderman ME, Ekhart TH, van Eijndhoven HW, van der Heijden OW, Peeters LL. Low plasma volume following pregnancy complicated by pre-eclampsia predisposes for hypertensive disease in a next pregnancy. BJOG 2003;110:1001-1006 (Pubitemid 37338489)
17. Alberti KG, Zimmet P, ShawJ; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062
18. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA 2001; 285:2486-2497
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published erratum appears in Circulation 2005;112:e297-8]. Circulation 2005;112:2735-2752
20. Mazar RM, Srinivas SK, Sammel MD, Andrela CM, Elovitz MA. Metabolic score as a novel approach to assessing preeclampsia risk. Am J Obstet Gynecol 2007;197:411.el-5.
21. Barden AE, Beilin LJ, Ritchie J, Walters BN, Michael C. Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertens 1999;17: 1307-1315
22. Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009;200:58.el-8.
23. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 2004;286: 1389-1393
24. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005;366: 1797-1803
25. 25. Wikstrom A, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG 2005;112:1486-1491 (Pubitemid 43961234)
26. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991;165:1408-1412
27. 27. Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG 2001;108:1081-1087 (Pubitemid 32971743)
28. Lampinen KH, Rönnback M, Groop PH, Kaaja RJ. A relationship between insulin sensitivity and vasodilation in women with a history of preeclamptic pregnancy. Hypertension 2008; 52:394-401.
29. 29. Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007;18: 234-239 (Pubitemid 46263364)
30. Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Davey Smith G, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 2007;335:978-987
31. 31. Manten GT, Sikkema MJ, Voorbij HA, Visser GH, Bruinse HW, Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 2007;26:39-50. (Pubitemid 46649339)
32. 32. Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004;89:6239-6243 (Pubitemid 39628439)